Latest News

Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for TEPEZZA® (teprotumumab-trbw) Effective Oct. 1, 2020

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced that the U.S. Centers for Medicare and Medicaid Services has assigned a permanent J-code (J3241) for TEPEZZA.

Source link

Related posts

UVA scientists develop a better way to determine what our genes do


Where Are Opioid Painkillers Prescribed the Most?


Medical News Today: Are some makeup ingredients toxic?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy